. Although two limitations of stent implantation are acute and subacute stent thrombosis, the incidence of thrombosis de- clined after the improvement of implantation techniques and pharmacological interventions of procedure protocols. Accordingly, the patients were put on antithrombotic prophylaxis via combined antiplatelet therapy with aspirin and ticic~pidin~ after stenting (3, 4) .
Activated platelets and leukocytes have been shown to play central roles in the development of thrombosis (5) (6) (7) (8) (9) (10) . Selectins are important adhesion molecules in cellto-cell interaction, involving circulating neutrophils and monocytes in the blood and the association with endothelium and activated platelets and leukocytes at the sites of tissue injury (11) (12) (13) (19, 20) . Because the adhesion molecules are shed from activated cells, increased levels of circulating soluble P-selectin, E-selectin, and L-selectin can be used as activation markers of platelets, endothelial cells, and leukocytes, respectively (21) (22) (23) (24) .
Coronary angioplasty has been shown to result in activation of platelets, leukocytes, and endothelial cells, despite aspirin and anticoagulant therapy (4, 6, 7, (25) (26) (27) (28) (29) (30) (31) 
RESULTS

Study population
Fifty-four patients with significant proximal left anterior descending artery were enrolled in study (41 (Fig. 1 ). Comparing the prestent sL-selectin concentrations to levels measured at hours 24 and 48 after stenting, significant decrease was found 48 hours after the procedure (P =0.001) (Fig. 2) . The level of se-selectin was significantly increased 24 hours and 48 hours after stent implantation (P = 0.0001 and P = 0.001, respectively) ( Table 4) .
Comparison of adhesion molecules levels among parents with A stent and NIR stent before and after stent placement Comparing the soluble P-selectin, se-selectin, and sLselectin levels measured before and after stent implanta- (33, 34) .
In previous studies, focusing on the platelet function after coronary angioplasty and stent implantation revealed platelets activation in patients receiving aspirin and heparin therapy (5) (6) (7) (24) (25) (26) (27) (28) (29) . However, in recent studies, platelet deactivation was shown in patients taking combined aspirin and ticlopidine after stent placement (4, 32, 35) . In accordance with these studies, we found that plasma sp-selectin levels decreased significantly after stent implantation in patients receiving com-9 bined antiplatelet therapy. Because (24, 26, 29, 31) . In the present study, we found a significant decrease in the soluble L-selectin level alter stenting in patients taking combined antiplatelet therapy. This result is consistent with the previous study that showed leukocyte deactivation in patients taking combined antiplatelet therapy after stent placement (32 (47) . Activated platelets adhere to leukocytes through P-selectin (45) . P-selectin leads to the capture of circulating leukocytes into the of tissue injury. As a result of our study, decreases in the circulating sp-selectin, a~fl~~tin~ platelet dcacti--vation, could result in decreased, binding of platelets to leukocytes, which potentially attenuates the inflammatory process and causes thrombogenesis. This observation might be one of the mechanisms for sl-selectin decrease after stenting.
;
In previous studies, se-selectin levels were found to be increased after coronary balloon angioplasty (26, 30) . Balloon angioplasty and stent implantation mechanically disrupt the atherosclerotic plaque, and, consequently, produce endothelial injury. In our present study, the in- 
